Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 9/2009

01-09-2009 | Editorial

99Mo supply—the times they are a-changing

Author: Dewi M. Lewis

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 9/2009

Login to get access

Excerpt

Recently there has been a phenomenal growth in clinical PET using 18FDG as well as a resurgence of interest in imaging with 123I. However, 99mTc still remains the most popular radionuclide; approximately 80% of all the world’s nuclear medicine procedures are carried out using 99mTc. The supply of its parent radionuclide (99Mo) relies on access to nuclear research reactors and nuclear fission radiochemical processing. During the last 18 months, there have been supply problems with both the reactors and radiochemistry operations; therefore, it is timely to re-visit this issue and examine the options that exist for 99Mo supply in Europe. …
Literature
1.
Metadata
Title
99Mo supply—the times they are a-changing
Author
Dewi M. Lewis
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 9/2009
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-009-1171-4

Other articles of this Issue 9/2009

European Journal of Nuclear Medicine and Molecular Imaging 9/2009 Go to the issue

Original Article

In vitro characterization of 177Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study

Short Communication

18F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK)

Image of the Month

Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging

Original Article

Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with 64Cu-DOTA-trastuzumab

Original Article

Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients

Original Article

The influence of Bz-DOTA and CHX-A″-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for 114mIn-mediated targeting therapy